Red Oak Medicines

Red Oak Medicines is a private, early-stage healthcare/biotechnology company based in Natick, Massachusetts. Publicly accessible information indicates the company was founded in 2017, raised a Series A financing of about $2.1 million in 2018, and has remained largely in stealth mode. Available third-party databases classify it within pharmaceuticals and biotechnology, but there is not enough reliable public disclosure to define a specific pipeline, modality focus, or therapeutic area with confidence. The company appears to be active as a corporate entity, with leadership references including Hongtao Li and board association by David Scadden. Because Red Oak Medicines has very limited public operating disclosure, many scientific and commercial fields remain undisclosed or unverified.